[1] Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum[M]. // Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon:IARC Press, 2000:105-119.

[2] Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum[M]. //Carneiro F, Hruban RH, et al, eds. World Health Organization Tumours. WHO Classification of Tumours of the Digestive System. Lyon:IARC Press, 2010:134-146.

[3] Juan Rosai. Rosai and Ackerman's Surgical Pathology[M]. 10th ed. New York:Elsevier Inc, 2011:731.

[4] Dixon MF. Gastrointestinal epithelial neoplasia:Vienna revisited[J]. Gut, 2002, 51(1): 130-131.

[5] Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract:advantages and disadvantages[J]. Virchows Arch, 2003, 442(2): 99-106.

[6] Toon CW, Walsh MD, Chou A, et al. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome[J]. Am J SurgPathol, 2013, 37(10): 1592-1602.

[7] MacDonald AW, Tayyab M, ArsaIaniZadch R, et al. Intramucosal carcinoma on biopsy reliably predicts invasive colorectal cancer[J]. Ann Surg Oncol, 2009, 16(12): 3267-3270.

[8] Fujimori T, Fujii S, Saito N, et al. Pathological diagnosis of early colorectal carcinoma and its clinical implications[J]. Digestion, 2009, 79(Suppl 1): 40-51.

[9] 郑洁. 结直肠息肉和结直肠癌[J]. 中华病理学杂志，2005，34（1）：4-5.

[10] Inamura K, Yamauchi M, Nishihara R, et al. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma[J]. Ann Surg Oncol, 2015, 22(4): 1226-1235.

[11] Mekenkamp LJ, Heesterbeek KJ, Koopman M, et al. Mucinous adenocarcinomas:poor prognosis in metastatic colorectal cancer[J]. Eur J Cancer, 2012, 48(4): 501-509.

[12] Verhulst J, Ferdinande L, Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer:a systematic review and meta-analysis[J]. J Clin Pathol, 2012, 65(5): 381-388.

[13] Edge SB, Byrd SR, Compton CC, et al. AJCC Cancer Staging Manual, 7th edition[M]. New York:Springer-Verlag, 2010:143-164.

[14] 中国胃肠胰神经内分泌肿瘤病理专家组. 中国胃肠胰神经内分泌肿瘤病理学诊断共识[J]. 中华病理学杂志，2011，40（4）：257-262.

[15] Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvantchemoradiotherapy for locally advanced rectal cancer[J]. Histopathology, 2005, 47(2): 141-146.

[16] Trakarnsanga A, Gönen M, Shia J, et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment[J]. J Natl Cancer Inst, 2014, 106(10): dju248 doi:10. 1093/jnci/dju248.

[17] Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer[J]. J Clin Oncol, 2010, 28(15S): 3511.

[18] 国家卫生计生委医政医管局，中华医学会肿瘤学分会. 中国结直肠癌诊疗规范（2015版）[J]. 中华胃肠外科杂志，2015，18（10）：961-973.

[19] 延丽雅，陈剑，张坤，等. 结直肠转移肿瘤53 例临床病理分析[J]. 临床与实验病理学杂志，2015，31（4）：372-327.

[20] Jiang W, Roma AA, Lai K, et al. Endometriosis involving the mucosa of the intestinal tract:a clinicopathologic study of 15 cases[J]. Mod pathol, 2013, 26(9): 1270-1278.